Agree, the MC of $3.5B for HER-Vaxx which wasn't even near Ph2 clinical trial completion was way overvalue by the market but IMU has added 3 other IP in the massive solid and blood cancer market with each IP having FDA IND and one with Fast Track Designation and another with a path to registrational clinical trial allowing for quicker commercialisation path.
Surely even you can see these markets will far eclipse the Chemotherapy market and IMU has also increased their cash balance while advancing the development of these 3 IP for 12-24 months with no negative clinical trial update since your investment in HER-Vaxx so why wouldn't the MC reach $1.5B??? I say 20c is only a fraction of IMU's worth provide everything goes as plan.
Why IMU is a multi multi bagger, page-25022
-
- There are more pages in this discussion • 436 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.002(3.51%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.9¢ | 5.5¢ | $1.012M | 18.02M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 590122 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 1408449 | 3 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |